Inés Maestro

873 citations
11 papers · 613 indexed · h-index 10

Inés Maestro

11 papers receiving 607 citations

Peers

Inés Maestro
Comparison fields: 5 of 93
  • Infectious Diseases 200
  • Computational Theory and Mathematics 170
  • Drug Discovery 1
  • Physiology 23
  • Neurology 68
Replace Rui Benfeitas with:
Rui Benfeitas Sweden
Vanesa Nozal Spain
Fisayo A. Olotu South Africa
Jiashu Xie United States
Rajni Khan India
Naveen Kumar Vishvakarma India
Babajan Banaganapalli Saudi Arabia
Lianzhou Huang China
J.A. Hernandez Prada United States
Nagarajan Raju India
Inés Maestro relative to Rui Benfeitas Sweden Rui Benfeitas's profile →
Citations per field
00.5×2.9×
Rui Benfeitas · 1×
Citations per year

Countries citing papers authored by Inés Maestro

Since Specialization
Citations

This map shows the geographic impact of Inés Maestro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés Maestro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés Maestro more than expected).

Fields of papers citing papers by Inés Maestro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inés Maestro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés Maestro. The network helps show where Inés Maestro may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Inés Maestro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inés Maestro Line = papers co-authored together Inés Maestro links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 20239
2 20235
3 20229
4 202122
5 2021139
6 202130
7 202123
8 202120
9 20219
10 202015
11 2020332

About Inés Maestro

Inés Maestro is a scholar working on Neurology, Physiology, Pharmacology, Pharmaceutical Science and Epidemiology, having authored 11 papers that have together received 613 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (5 papers), Amyotrophic Lateral Sclerosis Research (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), COVID-19 Clinical Research Studies (2 papers), Neurological diseases and metabolism (1 paper) and Neuroscience and Neuropharmacology Research (1 paper). The work is most often cited by research in Infectious Diseases (200 citations), Computational Theory and Mathematics (170 citations), Drug Discovery (1 citation), Physiology (23 citations) and Neurology (68 citations). Inés Maestro has collaborated with scholars based in Spain, Chile and Norway. Frequent co-authors include Ana Martı́nez, Carmen Gil, Vanesa Nozal, Nuria E. Campillo, David Ramírez, Tiziana Ginex, Miguel Ángel Cuesta-Geijo, Covadonga Alonso, Jesús Urquiza and Lucía Barrado-Gil. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Enzyme Inhibition and Medicinal Chemistry, Autophagy, Pharmaceuticals and ACS Chemical Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026